• $2.4B
    Market Cap
  • 337.80%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$3.55
$3.65
$3.59
1-Year Range
$0.77
$4.70
$3.59
Latest Close$3.59
Change
-$0.05 (-1.39%)
Volume735,817
Market Cap$2.4B
Shares Outstanding698.2M
P/E (TTM)-10.01
Diluted EPS (TTM)-$0.35
Enterprise Value$2.9B

Information as of 06/02/2026

Company Profile

Curaleaf Holdings, Inc.
https://www.curaleaf.com
$2.4B
Market Cap
-$231.1M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
290 Harbor Drive, Stamford, CT, United States, 06902
781 451 0159

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

Key Executives

  • Boris Alexis Jordan
  • Matthew S. Darin
  • Edward Kremer
  • Joseph F. Lusardi
  • Peter Laurence Clateman

Current Ownership Distribution

  • Other576.7M (72.75%)
  • Mutual Funds192.9M (24.33%)
  • Institutions23.2M (2.92%)
  • Insiders0 (0.00%)